It’s impossible to talk about cancer without realizing that everybody’s life has been touched by it either directly or indirectly. In the United States, half of women and one-third of men will be afflicted with cancer in their lifetime, and it still ranks as the second leading cause of all death, only a hair behind atherosclerosis.

But unlike heart disease, cancer lethality is even greater in mid-life than among seniors. In fact, for people between the ages of 45 to 65, cancer is the leading cause of death, killing more people than heart disease, liver disease, and stroke combined.

When thinking about how to prevent mortality from cancer, there are three key questions to consider: 

  1. (1) How do you prevent cancer? 
  2. (2) How do you screen for cancer to detect it early? 
  3. (3) How do you treat it when you have it?

Below is a collection of clips, podcasts, and articles discussing the latest science on cancer prevention, treatments, and the importance of cancer screening.


Peter on the importance of cancer screenings

This video clip is from AMA #25: Navigating the complexities and nuances of cancer screening, originally released on July 26,…

#290 ‒ Liquid biopsies for early cancer detection, the role of epigenetics in aging, and the future of aging research | Alex Aravanis, M.D., Ph.D.

Age is your single biggest risk factor for cancer. The population over 50 is about a 10x increased risk relative to the population under 50.” —Alex Aravanis

#289 – AMA #56: Cancer screening: pros and cons, screening options, interpreting results, and more

“There has been a pretty clear and consistent benefit [to cancer screening] that has been demonstrated, and the exceptions I think have a pretty clear sense of why.” —Peter Attia

#286 ‒ Journal club with Andrew Huberman: the impact of light exposure on mental health and an immunotherapy breakthrough for cancer treatment

People spend 90% of their time indoors now. Their daytime environments are too dim, their nighttime environments are too bright.” —Andrew Huberman

The futility of estimating changes to all-cause mortality from target cancer screening studies

Why a recent publication shouldn’t change your motivation to get screened for cancer

#278 ‒ Breast cancer: how to catch, treat, and survive breast cancer | Harold Burstein, M.D., Ph.D.

We’ve completely flipped the outcomes for HER2-positive breast cancer, where it has gone from one of the most feared types of breast cancer to one of the most successfully treated types of breast cancer.” —Harold Burstein

#273 ‒ Prostate health: common problems, cancer prevention, screening, treatment, and more | Ted Schaeffer, M.D., Ph.D.

The faster that your PSA density rises, it is a canary in the coal mine. . .you need to do some additional evaluation.” —Ted Schaeffer

Can a peptide found in bee stings offer hope for treatment-resistant breast cancers?

Melittin, the main component of honeybee venom, has shown promise as a basis for chemotherapeutic drugs to combat treatment-resistant breast cancer

#267 ‒ The latest in cancer therapeutics, diagnostics, and early detection | Keith Flaherty, M.D.

Early detection is going to allow our same toolbox of drugs to be massively more effective.” —Keith Flaherty

#252 ‒ Latest insights on Alzheimer’s disease, cancer, exercise, nutrition, and fasting | Rhonda Patrick, Ph.D.

My perspective has shifted as any scientist that’s following data should… When new data comes out, you have to reassess things.” —Rhonda Patrick

Facebook icon Twitter icon Instagram icon Pinterest icon Google+ icon YouTube icon LinkedIn icon Contact icon